Clinical Trial Update: RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating RO4929097 with whole-brain radiation therapy or stereotactic radiosurgery for brain metastases from breast cancer was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• RO4929097 (RO4929097)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Solid Neoplasm, Extensive Stage Lung Small Cell Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-02-06